Canada/Australia Issues being faced in the regulation of nano-materials - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

Canada/Australia Issues being faced in the regulation of nano-materials

Description:

Canada/Australia Issues being faced in the regulation of nano-materials Deborah Willcocks Department of Health and Ageing, Government of Australia – PowerPoint PPT presentation

Number of Views:82
Avg rating:3.0/5.0
Slides: 10
Provided by: Mark1214
Learn more at: http://www.oecd.org
Category:

less

Transcript and Presenter's Notes

Title: Canada/Australia Issues being faced in the regulation of nano-materials


1
Canada/AustraliaIssues being faced in the
regulation of nano-materials
  • Deborah Willcocks Department of Health and
    Ageing, Government of Australia
  • Anne-Marie Pelletier New Substances Branch,
    Environment Canada

2
Australian and Canadian Approach to Regulating
Chemicals
  • Both countries
  • established informal interdepartmental nanotech
    networks
  • maintain watching briefs on international
    activities
  • Recent review by scientific committee reporting
    to Australian Prime Minister identified need to
    address
  • Emerging safety implications
  • Development of a comprehensive impact and risk
    analysis framework

3
Australian and Canadian Approach to Regulating
Chemicals (cont.)
  • Australia and Canada have similar risk assessment
    programs for industrial chemicals
  • Identify substance by CAS , and name
  • Require tests of properties, toxicity,
    description of use and exposure
  • KEY ISSUES
  • Require globally harmonized definition of
    nano-materials
  • How different are nano-materials from ordinary
    chemicals?
  • Is the current regulatory approach adequate?

4
Nano-materials Regulation and Notification Issues
  • Regulatory definition / Substance identification
  • Require internationally accepted definition of a
    nano-materials
  • Measurement standards particles, tubes and
    wires, nanolayers and nanopores
  • Analytical methods and techniques - from all
    media including tissue
  • Nomenclature - standard chemical nomenclature
    adequate?
  • Regulatory system based on CAS - nano-material
    may be built from existing chemical? Same CAS
    - different substance, properties, hazard and
    use.
  • Product Classification
  • When is a nanomaterial an article?
  • Regulatory Framework
  • Analysis of current regulations needed - are
    existing regulatory frameworks suitable?

5
Nano-materials Regulation and Notification
Issues cont.
  • Current notification volume limits appropriate
    for nanoscale?
  • Some nanomaterials likely require lower volume
    limits given low anticipated manufacture, import
    and use volumes.
  • Current notification information requirements
    adequate?
  • Identification, properties, toxicity, etc
  • Based on hazard and exposure findings - should
    the requirements be modified for nanomaterials?
  • Test methods evaluation development
  • If tests and test methods inadequate
    Development of new methods
  • Toxicity tests requirements
  • Physchem property determination
  • Are current predictive tools adequate?
  • Labelling
  • Voluntary or mandatory labelling to identify
    nanosubstances for consumer goods?

6
Nano-materials Assessment Issues Knowledge Gaps
  • Technical capacity of assessors
  • Must be acquired to effectively assess and
    regulate
  • Exposure assessment
  • Lifecycle exposure determine release during
    manufacturing, processing, transportation, use
    disposal/recycling.
  • Can exposure be adequately modelled?
  • Monitoring data available?
  • Environmental Fate
  • Bioaccumulation and biomagnification potential
  • Persistence
  • Environmental partitioning
  • Transformation products identification and fate
  • Effects
  • Human and environmental hazards - chronic and
    acute effects?
  • Human health dermal, inhalation and oral
    exposure
  • Metabolic processes and fate
  • Can toxicity be modelled?

7
Nano-materials Risk Management Issues
  • Precautionary principle?
  • Voluntary measures?
  • Government/Industry co-operation?
  • No Action?

8
Stakeholder Involvement Communications
  • Government must be seen to be proactively
    addressing nanotechnology
  • Public must be informed and consulted
    perception is everything
  • Society needs to understand hazard and exposure
    issues, if any exist
  • Industry, academia other researchers
    involvement
  • NGO involvement ETC, Greenpeace, etc.
  • All levels of government involvement

9
Conclusion
  • Many unanswered questions
  • Globally at initial stages of regulation
  • Good opportunities for international cooperation
    and work sharing
  • Definition
  • Science
  • Regulatory framework development
  • Need to set priorities and focus effort
Write a Comment
User Comments (0)
About PowerShow.com